NASDAQ:LOAN - Manhattan Bridge Capital Stock Price, News & Analysis

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital announced a quarterly dividend on Monday, July 29th. Stockholders of record on Thursday, October 10th will be given a dividend of $0.12 per share on Tuesday, October 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 7.75%. The ex-dividend date of this dividend is Wednesday, October 9th. View Manhattan Bridge Capital's Dividend History.

Manhattan Bridge Capital Inc. (NASDAQ:LOAN) issued its quarterly earnings data on Friday, July, 26th. The credit services provider reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by $0.01. The credit services provider had revenue of $1.78 million for the quarter. Manhattan Bridge Capital had a return on equity of 13.60% and a net margin of 60.04%. View Manhattan Bridge Capital's Earnings History.

Manhattan Bridge Capital is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Manhattan Bridge Capital.

1 analysts have issued 12-month price targets for Manhattan Bridge Capital's stock. Their predictions range from $8.00 to $8.00. On average, they expect Manhattan Bridge Capital's stock price to reach $8.00 in the next year. This suggests a possible upside of 29.2% from the stock's current price. View Analyst Price Targets for Manhattan Bridge Capital.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Bridge Capital in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Manhattan Bridge Capital.

Headlines about LOAN stock have trended negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Manhattan Bridge Capital earned a daily sentiment score of -2.9 on InfoTrie's scale. They also gave press coverage about the credit services provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Manhattan Bridge Capital.

Manhattan Bridge Capital saw a decline in short interest in August. As of August 31st, there was short interest totalling 2,100 shares, a decline of 56.3% from the July 31st total of 4,800 shares. Based on an average daily trading volume, of 20,300 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the company's stock are short sold. View Manhattan Bridge Capital's Current Options Chain.

Some companies that are related to Manhattan Bridge Capital include BRT Apartments (BRT), CIM Commercial Trust (CMCT), Cherry Hill Mortgage Investment (CHMI), CBL & Associates Properties (CBL), Farmland Partners (FPI), Maxus Realty Trust (MRTI), Clipper Realty (CLPR), Ellington Residential Mortgage REIT (EARN), Sachem Capital (SACH), SOTHERLY HOTELS/SH SH (SOHO), Hunt Companies Finance Trust (HCFT), Reven Housing Reit (RVEN), AMEN Properties (AMEN), Tremont Mortgage Trust (TRMT) and Global Self Storage (SELF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), AcelRx Pharmaceuticals (ACRX), Corbus Pharmaceuticals (CRBP), Rigel Pharmaceuticals (RIGL), Ampliphi Biosciences (APHB), Actinium Pharmaceuticals (ATNM), Arbutus Biopharma (ABUS), ArQule (ARQL), Athersys (ATHX) and BGC Partners (BGCP).

Manhattan Bridge Capital's stock is owned by many different of institutional and retail investors. Top institutional investors include Bard Associates Inc. (2.40%), Renaissance Technologies LLC (2.19%), Shufro Rose & Co. LLC (0.99%), Capital Planning Advisors LLC (0.76%), Granite Investment Partners LLC (0.66%) and Moneta Group Investment Advisors LLC (0.57%). Company insiders that own Manhattan Bridge Capital stock include Assaf Ran and Lyron L Bentovim. View Institutional Ownership Trends for Manhattan Bridge Capital.

LOAN stock was sold by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Moneta Group Investment Advisors LLC, Renaissance Technologies LLC, Moneta Group Investment Advisors LLC and Bard Associates Inc.. View Insider Buying and Selling for Manhattan Bridge Capital.

LOAN stock was acquired by a variety of institutional investors in the last quarter, including Aptus Capital Advisors LLC, Shufro Rose & Co. LLC, Capital Planning Advisors LLC, National Asset Management Inc. and BlackRock Inc.. View Insider Buying and Selling for Manhattan Bridge Capital.

Shares of LOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LOAN stock can currently be purchased for approximately $6.19.

Manhattan Bridge Capital has a market capitalization of $59.80 million and generates $7.22 million in revenue each year. Manhattan Bridge Capital employs 4 workers across the globe.View Additional Information About Manhattan Bridge Capital.

The official website for Manhattan Bridge Capital is http://www.manhattanbridgecapital.com/.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The credit services provider can be reached via phone at 516-444-3400.